Description
Description
DESCRIPTION
Indications
Mantle Cell Lymphoma: Ibrutinib is indicated for the treatment of patients with Mantle Cell Lymphoma (MCL) who have received at least one prior therapy.Chronic Lymphocytic Leukemia/Smallymphocytic Lymphoma: Ibrutinib is indicated for the treatment of patients with chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with 17p deletion Ibrutinib is indicated for the treatment of patients with chronic lymphocytic leukemia.ยค
Pack size : 120 capsules.
Manufacturer :
Evarest pharmaceuticals limited.
Authorised Distributors :
Nasima Pharma
www.nasimapharma.com
+8801928359753
WhatsApp /Wechat
Reviews
There are no reviews yet.